Cytotoxic xanthone derivatives from the twigs of Garcinia oligantha.

Cytotoxic activity Garcinia oligantha merr. Xanthone derivatives clusiaceae

Journal

Phytochemistry
ISSN: 1873-3700
Titre abrégé: Phytochemistry
Pays: England
ID NLM: 0151434

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 10 12 2019
revised: 25 01 2020
accepted: 24 02 2020
pubmed: 24 3 2020
medline: 1 5 2020
entrez: 24 3 2020
Statut: ppublish

Résumé

Ten undescribed xanthone derivatives, garoliganthins A-I and oliganthaxanthone C, along with eight known compounds, were isolated from the twigs of Garcinia oligantha Merr. Their structures and absolute configurations were determined by extensive spectroscopic methods, single-crystal X-ray diffraction analysis, electronic circular dichroism analysis, and chiral HPLC/HPLC-CD analysis combined with density functional theory calculations. Garoliganthin A is an unprecedented tetrahydro-xanthone derivative possessing a bicycle [3.2.2] nonane skeleton, and garoliganthins B-E are the first examples of a new class of rearranged xanthone derivatives with six-membered lactone core scaffold. The cytotoxic effects of the isolates on four human cancer cell lines (HeLa, PC-3, A549, and K562) were measured using an MTT assay. Seven compounds showed good inhibitory activities against four cancer cell lines with IC

Identifiants

pubmed: 32203742
pii: S0031-9422(19)31192-6
doi: 10.1016/j.phytochem.2020.112329
pii:
doi:

Substances chimiques

Antineoplastic Agents, Phytogenic 0
Xanthones 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

112329

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declared that they have no conflicts of interest to this work. We declare that we do not have any commercial or associative interest that represents a conflict of interest in connection with the work submitted.

Auteurs

Jinling Yang (J)

School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, PR China.

Wenwei Fu (W)

School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, PR China. Electronic address: fu_wenwei@163.com.

Qian Xiang (Q)

School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, PR China.

Yuexun Tang (Y)

School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, PR China.

Rong Wu (R)

School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, PR China.

Changwu Zheng (C)

School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, PR China.

Yue Lu (Y)

School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, PR China.

Hua Zhou (H)

Institute of Cardiovascular Disease of Integrated Traditional Chinese and Western Medicine, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, PR China. Electronic address: zhouhuam@hotmail.com.

Hongxi Xu (H)

Institute of Cardiovascular Disease of Integrated Traditional Chinese and Western Medicine, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, PR China. Electronic address: xuhongxi88@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH